Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Third party research

Generic: Strong quarter and outlook - ABG

Generic Sweden

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
24% organic sales growth y-o-y
Improved gross margin due to price adjustments
Opex growth to abate in the coming quarters


Q3: Sales growth of 24%, EBIT margin of 20.6% (22.6%)

In our view, Generic's Q3 results were impressive. Sales growth remained strong at 24% y-o-y (all organic), the gross margin improved 130bp q-o-q to 41.5% and opex growth y-o-y was 15% (down from 21% in Q2). This resulted in sales of SEK 43m (35m) and EBIT of SEK 8.8m (7.8m), which was 1% above ABGSCe on sales and 11% on EBIT, as the gross margin was higher and opex lower than we anticipated. The improved gross margin q-o-q was a result of price hikes and a higher proportion of revenues from the company's Saas offering. Furthermore, management does not see any need for additional hirings in the short- to medium-term.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.